Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device
The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners.
Teal Health Teams Up With Thatch to Expand Access to Cervical Cancer Screening
Through a new partnership, Thatch’s employer customers can now offer Teal Health’s at-home cervical cancer screening as an employee benefit through an ICHRA.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Cancer Is on the Rise in Younger Adults: What Is the Healthcare Industry Doing About It?
Cancer rates are climbing among younger Americans, and healthcare leaders are calling for earlier screenings, more convenient testing options and expanded health plan coverage to help catch cases before they’re fatal. From at-home tests to multi-cancer detection tools, stakeholders across the industry are working to boost access to early detection.
FDA Approves First At-Home Cervical Cancer Test
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.
Meet the Company Developing an At-Home Test to Replace the Pap Smear
Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for its at-home cervical cancer screening kit, which seeks to give patients an alternative to the in-office pap smear.